Pharmacy Daily | A stronger AMR response in Asia-Pacific is needed

IT IS estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 - the most recent data - and contributed to 4.95 million deaths worldwide.

The misuse and overuse of antimicrobials in humans, animals and plants are the main drivers in the development of drug-resistant pathogens.

While AMR affects countries in all regions and at all income levels, its drivers and consequences are exacerbated by poverty and inequality, with low- and middle-income countries most affected.

The Asia-Pacific region has its unique set of challenges, problems and issues that warrant localised and contextualised tailored solutions.

"While we respect the global action plan on AMR, we need a tailored action plan and reports for this region," said Dr SS Lal, Asia-Pacific Director of AMR action group ReAct.

"We need regional alignment on priorities and long-term actions for AMR."

He pointed out that health systems in the Asia-Pacific region are different to those in other regions.

For example, in several countries of the region, the private healthcare sector serves the needs of the majority of the population, and it is unregulated in some countries.

And while most countries in the region have national action plans on AMR, some are yet to devise plans, while others have them but are yet to implement them.

"Working at national level is important but we also have to implement activities at sub-national level to prevent AMR - working only at national level may not achieve the results," said Dr Lal.

He stressed the importance of engaging civil society, youth and communities at all levels of AMR response.

"Early and accurate multi-disease diagnostics must be made accessible to all, ensuring no one is left behind.

"Early and accurate diagnosis is not only an entry to the treatment and care pathway, but also helps stops the spread of infections."

Dr Lal also highlighted the need for antimicrobial stewardship mechanisms in all healthcare facilities in all countries.

"Major healthcare facilities, where most antimicrobials are prescribed on a daily basis, should have standard stewardship mechanisms," he stated.

"We also must ensure that all people have access to most appropriate antimicrobials."

ReAct Europe Director Anna Sjoblom pointed out that healthy populations have fewer infections, and there is less need for antimicrobials.

"This means early and accurate diagnosis; optimal treatment, care and support; and infection prevention and control in healthcare facilities, the wider community and in homes," she said.

"Child and adult vaccination for vaccine-preventable illnesses is also important, as is clean water, sanitation and hygiene."

This article was contributed by Shobha Shukla, Chairperson of the Global AMR Media Alliance, who attended the Asia-Pacific Regional Conference on Antimicrobial Resistance (AMR) 2025 last week in Jakarta.